Powerful Cheminformatics Software for Discovery Scientists

Affordable, Extensible Solution Available to Organize, Analyze and Visualize Chemical and Biological Data

WASHINGTON–Tripos™, a leading provider of drug discovery informatics products and services, today announced the release of Benchware® Pantheon™, a new software solution that enables discovery scientists to rapidly and accurately merge data from multiple sources, and then analyze and visualize that data for faster and better decision making. Researchers can integrate and translate various spreadsheets, merge biological data with chemical structures, and then use a range of tools to sort, analyze and visualize data in 2D and 3D.

“What makes Pantheon unique is the combination of a chemically aware spreadsheet and ‘grid view,’ with powerful 3D molecular visualization,” states Brian Masek, Ph.D., Tripos’ Product Manager and Senior Scientist. “With Pantheon, scientists can quickly and easily visualize the binding interactions of a drug candidate with its receptor and also view all the biological testing data and molecular properties of the candidate. Pantheon gives discovery scientists the full picture of their data.”

Pantheon also provides simple but powerful communication capability between and among scientific team members. Scientists can share their findings with colleagues by e-mail, and take advantage of Pantheon’s powerful integration with key industry standard productivity tools, such as Microsoft’s Excel® and PowerPoint®. With Pantheon, 3D molecular images embedded in PowerPoint are fully interactive, and can be rotated, scaled and modified as needed.

About Tripos

Tripos, a Certara™ Company, is a global leader in innovative scientific solutions enabling life science researchers to improve the efficiency of molecular discovery. Established in 1979, Tripos was the first company to bring scientific computational drug discovery capabilities to the pharmaceutical, chemical and food design industries, and today helps a broad range of companies and research facilities accelerate the identification and optimization of new compounds that have the potential to become marketed drugs, foods, flavorings and fragrances. Headquartered in St. Louis, Missouri, Tripos serves more than 1,000 customers spanning over 46 countries.

About Certara

Certara is dedicated to improving human health through a broad spectrum of products and services, from molecular discovery to clinical research. Formed in 2008, Certara unites Tripos (www.tripos.com) and Pharsight Corporation (www.pharsight.com). Tripos is a global leader in innovative scientific solutions enabling life science researchers to improve the efficiency of molecular discovery. Pharsight is the leading provider of software and scientific services to improve productivity and decision-making in clinical drug development. Certara expects to provide its clients with important new products, key enabling technologies and scientific expertise to expedite the flow of information throughout drug discovery and development. Certara is focused on reducing the barriers between the phases of research that will speed discoveries in chemistry and enable pharmaceutical and biotechnology companies to achieve significant and enduring improvements in the development and use of therapeutic products.